Commonwealth Equity Services’s BioAtla BCAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.07K Hold
506
﹤0.01% 4293
2025
Q4
$14.4K Hold
506
﹤0.01% 4254
2025
Q3
$17K Hold
506
﹤0.01% 4213
2025
Q2
$10K Hold
506
﹤0.01% 4232
2025
Q1
$9K Buy
506
+70
+16% +$1.5K ﹤0.01% 4151
2024
Q4
$13K Hold
436
﹤0.01% 4058
2024
Q3
$38K Hold
436
﹤0.01% 3957
2024
Q2
$30K Sell
436
-44
-9% -$5.24K ﹤0.01% 3936
2024
Q1
$83K Buy
480
+44
+10% +$5.47K ﹤0.01% 3830
2023
Q4
$54K Hold
436
﹤0.01% 3749
2023
Q3
$37K Hold
436
﹤0.01% 3685
2023
Q2
$65K Hold
436
﹤0.01% 3628
2023
Q1
$58 Buy
436
+36
+9% +$6.48K ﹤0.01% 3564
2022
Q4
$165K Buy
+400
New +$166K ﹤0.01% 3303
2022
Q3
Sell
-280
Closed -$39K 3670
2022
Q2
$39K Buy
+280
New +$44.6K ﹤0.01% 3516

Other funds holding BCAB

Commonwealth Equity Services's BCAB Position: Q1 2026 in Review

Commonwealth Equity Services held its BioAtla (BCAB) position steady in Q1 2026 at 506 shares worth $4.07K. The position accounts for ﹤0.01% of the portfolio, ranked #4293.

Commonwealth Equity Services first reported a position in BCAB in Q2 2022 and has held it in 15 quarters since. The position peaked at $165K in Q4 2022. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

  • Commonwealth Equity Services held 506 shares of BioAtla worth $4.07K as of Q1 2026.
  • Commonwealth Equity Services left its BioAtla share count unchanged in Q1 2026.
  • BioAtla made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #4293 holding.
  • Commonwealth Equity Services first reported a position in BioAtla in Q2 2022 and has held it in 15 quarters since.
  • Commonwealth Equity Services's BioAtla position peaked at $165K in Q4 2022.
  • 36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.